当前位置: X-MOL 学术Alzheimers Dement. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2024-12-06 , DOI: 10.1002/alz.14373
Jielin Xu 1, 2 , Wenqiang Song 1 , Zhenxing Xu 3, 4 , Michael M Danziger 5 , Ehud Karavani 5 , Chengxi Zang 3, 4 , Xin Chen 1, 2 , Yichen Li 1, 2 , Isabela M Rivera Paz 2 , Dhruv Gohel 1, 2 , Chang Su 3, 4 , Yadi Zhou 1, 2 , Yuan Hou 1, 2 , Yishai Shimoni 5 , Andrew A Pieper 6, 7, 8, 9, 10 , Jianying Hu 11 , Fei Wang 3, 4 , Michal Rosen-Zvi 5 , James B Leverenz 12 , Jeffrey Cummings 13 , Feixiong Cheng 1, 2, 14
Affiliation  

High microglial heterogeneities hinder the development of microglia-targeted treatment for Alzheimer's disease (AD).

中文翻译:


基于单小胶质细胞转录组转换网络的预测和真实世界患者数据验证确定酮咯酸是阿尔茨海默病的可再利用药物



高小胶质细胞异质性阻碍了阿尔茨海默病 (AD) 小胶质细胞靶向治疗的发展。
更新日期:2024-12-06
down
wechat
bug